Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

DCAF7 Antikörper (N-Term)

DCAF7 Reaktivität: Human, Maus WB Wirt: Kaninchen Polyclonal unconjugated
Produktnummer ABIN928603
  • Target Alle DCAF7 Antikörper anzeigen
    DCAF7 (DDB1 and CUL4 Associated Factor 7 (DCAF7))
    Bindungsspezifität
    • 15
    • 14
    • 7
    • 4
    • 2
    N-Term
    Reaktivität
    • 32
    • 29
    • 12
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Human, Maus
    Wirt
    • 45
    • 2
    Kaninchen
    Klonalität
    • 47
    Polyklonal
    Konjugat
    • 16
    • 4
    • 3
    • 3
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    Dieser DCAF7 Antikörper ist unkonjugiert
    Applikation
    • 37
    • 18
    • 13
    • 13
    • 5
    • 4
    • 3
    • 3
    • 1
    • 1
    Western Blotting (WB)
    Kreuzreaktivität
    Maus
    Aufreinigung
    Purified
    Immunogen
    Dcaf7 antibody was raised in rabbit using the N terminal of Dcaf7 as the immunogen
    Top Product
    Discover our top product DCAF7 Primärantikörper
  • Applikationshinweise
    Optimal conditions should be determined by the investigator.
    Kommentare

    Dcaf7 Blocking Peptide, catalog no. 33R-8588, is also available for use as a blocking control in assays to test for specificity of this Dcaf7 antibody

    Beschränkungen
    Nur für Forschungszwecke einsetzbar
  • Format
    Lyophilized
    Konzentration
    Lot specific
    Buffer
    Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
    Handhabung
    Avoid repeated freeze/thaw cycles.
    Lagerung
    4 °C/-20 °C
    Informationen zur Lagerung
    Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
  • Target
    DCAF7 (DDB1 and CUL4 Associated Factor 7 (DCAF7))
    Andere Bezeichnung
    Dcaf7 (DCAF7 Produkte)
    Synonyme
    wdr68 antikoerper, han11l antikoerper, fj83g06 antikoerper, zgc:63940 antikoerper, wu:fj83g06 antikoerper, cg14614 antikoerper, MGC53476 antikoerper, MGC80168 antikoerper, MGC75622 antikoerper, WDR68 antikoerper, AN11 antikoerper, HAN11 antikoerper, SWAN-1 antikoerper, 1700012F10Rik antikoerper, 2610037L01Rik antikoerper, C86529 antikoerper, Wdr68 antikoerper, RGD1305140 antikoerper, ddb1 and cul4 associated factor 7 antikoerper, DDB1 and CUL4 associated factor 7 S homeolog antikoerper, DDB1 and CUL4 associated factor 7 antikoerper, dcaf7 antikoerper, dcaf7.S antikoerper, DCAF7 antikoerper, Dcaf7 antikoerper
    Hintergrund
    Dcaf7 is involved in craniofacial development. It acts upstream of the EDN1 pathway and is required for formation of the upper jaw equivalent, the palatoquadrate. The activity required for EDN1 pathway function differs between the first and second arches. It associates with DIAPH1 and controls GLI1 transcriptional activity. It could be involved in skin development. It may function as a substrate receptor for CUL4-DDB1 E3 ubiquitin-protein ligase complex. Synonyms: Polyclonal Dcaf7 antibody, Anti-Dcaf7 antibody, DDB1 and CUL4 associated factor 7 antibody, 1700012F10Rik antibody, 2610037L01Rik antibody, C86529 antibody, HAN11 antibody, Wdr68 antibody.
    Pathways
    SARS-CoV-2 Protein Interaktom
Sie sind hier:
Kundenservice